PRA SUCCESSFULLY RESCUES PHASE II HEMATOLOGY STUDY Effective Project Plan Identifies Risks, Enables Timely Transition PR A HEAL TH SCIEN CES CASE STUDYTHE FUTURE OF CLINICAL DEVELOPMENT. REGIONS STUDY DESCRIPTION administered as adjunctive treatment to patients with acquired thrombotic thrombocytopenic purpura North America Western Europe Central & Eastern Europe Middle East Asia Paci?c TREATMENT PERIOD DAYS 90 PATIENT POPULATION 110 N o. OF C

Join for free to read